Clinical Trials Logo

Childhood ALL clinical trials

View clinical trials related to Childhood ALL.

Filter by:

NCT ID: NCT04120896 Not yet recruiting - Childhood ALL Clinical Trials

Karate or Kung Fu?

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Sedentary lifestyle in Asian children together with aversive parenting style may compromise their physical and psychological health. The aim of the proposed stratified, randomized controlled study are to explore the beneficial effects of Japanese martial art (karate) and Chinese martial art (Ving Tsun kung fu) training on improving the psychophysical health in this population. Over fifty-two Asian children (age = 6-12 years) will be recruited from schools in Hong Kong and then randomly assigned to either a karate group or a Ving Tsun group. Children in both groups will receive the respective physical and spiritual martial art training for 3 months (3 times/week, one hour each). Outcomes will be evaluated at baseline and after the intervention by a blinded assessor. Primary outcomes include muscle power of the arms and legs as measured by a medicine ball throw test and a standing long jump test, respectively. Secondary outcomes include flexibility as quantified by a sit-and-reach test, aggression as measured by the Reactive-Proactive Aggression Questionnaire, and attention as measured by the Child Behavioral Checklist-Youth Self-Report. Both karate and Ving Tsun kung fu training programs are predicted to improve physical health of Asian children. It is expected that these training programs can be incorporated into the physical education classes or extracurricular activities in schools or in the community to improve project sustainability.

NCT ID: NCT01733953 Active, not recruiting - Clinical trials for Cardiovascular Disease

Statin Therapy in Young Adult Survivors of Childhood Cancer

Start date: November 2012
Phase: Phase 2
Study type: Interventional

Adult survivors of childhood cancer are at high risk of developing cardiovascular disease. Therapies used to treat many cancers, such as chemotherapy and radiation, likely cause damage to the surface of the artery wall called the endothelial layer, leading to the induction of atherosclerosis and eventual cardiovascular disease. HMG coenzyme A reductase inhibitors, or statins, improve endothelial function independent of cholesterol-lowering. In addition, statins have been shown to reduce arterial stiffness and slow arterial thickening. Despite strong evidence supporting the vascular benefits of statins in many different patient populations, these medications have never been studied in cancer survivors. Therefore, the overall objective of this study is to evaluate the effects of statin therapy on vascular health in young adult survivors of childhood cancer. Twenty-four young adult (age 18-39 years old) survivors of childhood acute lymphoblastic leukemia (ALL) or non-Hodgkin's lymphoma (NHL) will be enrolled in a six-month randomized, double-blind (participants and investigators), placebo-controlled pilot clinical trial comparing the effects of atorvastatin versus placebo on endothelial function and other measures of vascular health. Our primary objective is to evaluate the effects of 6-months of statin therapy on conduit artery endothelial function in young adult survivors of childhood cancer. The investigators hypothesize that, compared to placebo, atorvastatin will significantly increase brachial artery flow-mediated dilation in survivors of childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.